RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
about
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisIntracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesCell-type specific penetrating peptides: therapeutic promises and challengesRecent Developments in Peptide-Based Nucleic Acid DeliveryDelivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challengesCell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts.Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.Synthesis and gene silencing properties of siRNAs containing terminal amide linkages.Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.Distribution of CPP-Protein Complexes in Freshly Resected Human Tissue Material.The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorptionA role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittinA versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water.Delivery of intracellular-acting biologics in pro-apoptotic therapies.Inhibiting gene expression with peptide nucleic acid (PNA)--peptide conjugates that target chromosomal DNA.Cell-penetrating peptides for drug delivery across membrane barriers.Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.Concepts in in vivo siRNA delivery for cancer therapy.Cellular delivery and photochemical activation of antisense agents through a nucleobase caging strategy.Targeted delivery systems for oligonucleotide therapeutics.Chemically modified cell-penetrating peptides for the delivery of nucleic acids.Focus on PNA Flexibility and RNA Binding using Molecular Dynamics and Metadynamics.Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications.Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.Cell-penetrating peptides for the delivery of nucleic acids.Advances in targeted delivery of small interfering RNA using simple bioconjugates.Sequence-defined polymers for the delivery of oligonucleotides.Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.Cationic cell-penetrating peptides as vehicles for siRNA delivery.Functional peptides for siRNA delivery.Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Building Cell Selectivity into CPP-Mediated Strategies.Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.Effective endogenous gene silencing mediated by pH responsive peptides proceeds via multiple pathways.Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein.Increased RNAi is related to intracellular release of siRNA via a covalently attached signal peptide.Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse.
P2860
Q26782089-89F9C499-4A8D-46F9-8673-C201D5FDCE00Q26795943-287772C5-7EFF-4459-8D6C-FDB5E9EBD09BQ26800103-9DD67D24-44E0-4DA1-9ACA-71462CB33F4FQ27487857-4771BB4B-3065-48E8-8509-A48568F913F0Q28087352-0E669BAE-B6DC-4D0A-B299-87E469FD31BFQ30493854-2FD11C5C-C5F3-4745-983B-DDB10AE0FE2AQ31137535-D8F3BDD6-23F2-42A7-8FE4-4271D6097467Q33282788-CE8150F6-F27E-41ED-8875-E486C707FB30Q33358371-6F40C509-F875-43A0-8734-F41032D3BCCAQ33359116-CE101C07-F6F3-440A-BB16-97EA22E7B8B3Q33664219-40EA253B-35AB-4196-844E-6FD9AAC3F444Q34829819-0CE5F656-7B36-4A4D-AF60-8C4F3F26753BQ35967737-E50385C7-F1CD-4E99-B968-6A0C3555A2F3Q36328980-04B16209-9EFF-414F-AC70-45274C50E48DQ36588920-31135CFB-0AAC-4E7D-B40D-EA4CBC0655B9Q36930752-55370C0D-E4A7-42E1-A8DA-4E5635BA3F3BQ37039034-7465FD20-C52D-49EF-A4F5-EB67DB3E743CQ37043911-757DB5E5-0335-4A67-A0D3-FBD7F125E9D6Q37217876-33E12DC3-584D-4C7F-B34B-94CC4BD5333EQ37376458-60305FD8-E510-4AB2-B8DA-93761300D20BQ37417572-1E8287EC-4153-4DA4-9D16-4A6960E2A8C7Q37615342-EA27A4AB-1544-4C03-BEFE-A0991284612AQ37648615-E8EBF2ED-EA8F-4F19-82FE-57148B8C2A4BQ37869397-C2F79A2A-3CA8-4DA3-817F-096EA90CE3B1Q37921384-2BDEC05E-18E9-4D03-A68B-E004C97A2B0CQ37962609-529955EB-4596-477C-AF7A-3BA0EB655985Q38010767-F39FFA3F-9559-4DB7-81A3-6B6AFCE26EE3Q38199518-57E0A979-16CF-4C32-9AAB-5E9D7B92BC0DQ38298812-1AD2B88B-1C2F-4909-BFD6-8025E9032F62Q38300633-7CFF7D2C-65EA-4CF2-9539-6D933E4CC014Q38325571-2D997777-678B-435F-B728-8A9A5243FBB7Q38495028-4E1381C4-968A-4F92-9602-FA4F00C36945Q38928987-3F7C3ACA-955B-4E52-9818-07E0A349249AQ38974236-CB50E9D1-3E59-4213-9CDF-3798CB8A2042Q38974301-987E10F4-4B5A-4EF4-BE92-9D03F7E361CBQ39145426-F313B30E-D734-47E5-ABA2-B055F0F9DB18Q39433772-38DA4CF0-036D-4D9F-A698-F27C31C12F6EQ39850218-45FFE70A-8E30-45FE-B9C1-E3CA9F9D5CA0Q39882078-6D3CBD68-3F23-43C5-A2E4-92CA93DC5FBEQ39882118-D827D3FF-8F02-4587-B241-E69E8329C9BA
P2860
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@ast
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@en
type
label
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@ast
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@en
prefLabel
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@ast
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@en
P2093
P1476
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
@en
P2093
Andrey A Arzumanov
Gabriela Ivanova
John J Turner
Martin M Fabani
Michael J Gait
Simon Jones
P356
10.1016/J.BCMD.2006.10.003
P577
2006-11-17T00:00:00Z